TLR4 and chronic kidney disease: These results suggest that tRF-003634 may reduce the stability of TLR4 mRNA by competitively binding to YTHDC1, thereby down-regulating the expression of TLR4 and alleviating podocyte injury in vitro and in vivo, providing a new strategy for the prevention and treatment of CKD (Fig. 3).